Key Takeaways
- Oracle shares tumbled over 6% following Apple’s legal action against OpenAI, casting doubt over Oracle’s massive $300 billion collaboration with the artificial intelligence firm
- S&P Global cut Oracle’s credit rating to BBB- from BBB, pointing to increased business risk exposure
- The company disclosed plans to invest as much as $95 billion in capital spending by fiscal 2027, significantly exceeding analyst projections
- OpenAI represents approximately 50% of Oracle’s total remaining performance obligations, presenting significant customer concentration concerns
- Analysts maintain a Strong Buy rating on Oracle despite recent weakness, with a consensus price target of $263.86 — representing potential upside of roughly 95% from current trading levels
Oracle’s stock has been under intense pressure lately. Following its June 10 quarterly results, ORCL shares have plummeted approximately one-third in value, with Monday’s sharp 6%-plus decline deepening investor losses.
The catalyst behind Monday’s selloff was Apple’s decision to sue OpenAI, claiming the artificial intelligence firm misappropriated proprietary information. This development is significant for Oracle given its enormous $300 billion arrangement with OpenAI focused on constructing AI infrastructure and providing computational resources.
Any litigation challenges facing OpenAI cast uncertainty over whether the company can fulfill its contractual commitments — a scenario that’s clearly making shareholders uneasy.
The Apple litigation isn’t the only headwind battering the stock. S&P Global recently lowered Oracle’s credit rating one notch to BBB- from BBB. The ratings agency cited elevated business risk and warned that if OpenAI defaulted on payments, Oracle could find itself stuck with enormous data center lease obligations it cannot terminate.
According to S&P’s analysis, OpenAI accounts for approximately half of Oracle’s total remaining performance obligations. This degree of revenue concentration presents substantial risk for a corporation assuming considerable debt loads.
Massive Capital Spending Plans Raise Eyebrows
Oracle’s June quarterly results appeared impressive initially — both revenue and profit exceeded forecasts, while executives highlighted explosive growth in demand for AI-powered cloud infrastructure. However, investors quickly focused on the enormous costs required to satisfy that demand.
Executives revealed the company anticipates capital expenditures reaching $95 billion by fiscal year 2027, substantially higher than Wall Street’s estimates. Oracle also intends to secure approximately $40 billion through debt issuance and equity offerings to finance this aggressive expansion.
Additionally, management cautioned that gross profit margins will compress as newly constructed AI data centers launch operations before achieving optimal capacity. This trifecta — extraordinary spending requirements, equity dilution, and compressed margins — triggered the sharp stock decline.
Oracle shares traded around $131.80 on Monday, well off their 52-week peak of $345.72.
Contrarian Viewpoint Emerges
Not all market participants are bailing out. Steven Fiorillo, who ranks among the top 1% of equity analysts on TipRanks, believes the market reaction has been excessive.
“The market chose to price all the risk and none of the CapEx conversion, which I believe is our opportunity,” Fiorillo said.
He contends that Oracle’s expanding backlog of committed contracts will translate into revenue streams once new facilities become operational, and that customers increasingly financing their own infrastructure reduces Oracle’s capital burden.
Fiorillo also highlights that Oracle has embedded contractual pricing adjustments that allow the company to transfer escalating construction and equipment costs to customers.
While he recognizes the challenges — mounting debt obligations, continued capital market activity, negative free cash flow projected for at least another year, and substantial dependence on a single customer — Fiorillo believes these concerns are already priced into current valuations. “I am very bullish on ORCL at these levels,” he stated.
Wall Street analysts largely share the view that the stock has been oversold. Oracle maintains a Strong Buy consensus rating from 31 analysts, with 28 issuing Buy recommendations and 3 rating it a Hold. The average analyst price target stands at $263.86.





